Private company

CohBar, Inc.

American pharmaceutical preparations company, incorporated in Delaware.

Last updated Oct 18, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE2
  • Business address1455 Adams Drive, Suite 2050, Menlo Business Park, Menlo Park, Ca 940252
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income345678-$12.4M in 2022+104% since 2016
-$20.0M-$15.0M-$10.0M-$5.0M02016: -$6.1M-$6.1M20162017: -$9.9M-$9.9M2017+62%2018: -$15.3M-$15.3M2018+56%2019: -$12.6M-$12.6M2019−18%2020: -$13.2M-$13.2M2020+5%2021: -$15.4M-$15.4M2021+17%2022: -$12.4M-$12.4M2022−20%
Net income345678-$12.2M in 2022+100% since 2016
-$20.0M-$15.0M-$10.0M-$5.0M02016: -$6.1M-$6.1M20162017: -$9.8M-$9.8M2017+62%2018: -$15.7M-$15.7M2018+60%2019: -$13.0M-$13.0M2019−17%2020: -$16.3M-$16.3M2020+25%2021: -$15.5M-$15.5M2021−5%2022: -$12.2M-$12.2M2022−21%
Fiscal year20162017201820192020202120222023
Research and development$3.6M3$6.7M4$10.0M5$6.6M6$6.9M7$7.7M8$5.9M8
Operating income-$6.1M3-$9.9M4-$15.3M5-$12.6M6-$13.2M7-$15.4M8-$12.4M8
Interest$7.6K3$3.6K4$232.0K5$312.2K5
Net income-$6.1M3-$9.8M4-$15.7M5-$13.0M6-$16.3M7-$15.5M8-$12.2M8
Earnings per share-$6.978-$4.208
Earnings per share (diluted)-$6.978-$4.208

Compare CohBar, Inc. with another company

Leadership

Who has led CohBar, Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (15)

Timeline

  1. May 20, 2021New chief executive Joseph J. Sarret becomes CEO13
  2. May 17, 2019New chief executive Steven B. Engle becomes CEO14
  3. Dec 10, 2018New chief executive Philippe Calais becomes CEO15
  4. Mar 8, 2016New chief executive Simon Allen becomes CEO16
  5. Dec 19, 2014New chief executive Jon Leland Stern becomes CEO17

Filings

73 filings to the SEC since October 2021: 3 annual reports, 6 quarterly reports, 22 major events, 9 insider forms, 6 large holders, 27 other. The latest 20:

  1. Nov 27, 20238-K CURRENT REPORT EDGAR
  2. Nov 13, 20238-K CURRENT REPORT EDGAR
  3. Nov 1, 20238-K CURRENT REPORT EDGAR
  4. Oct 25, 2023425 CURRENT REPORT EDGAR
  5. Oct 25, 20238-K CURRENT REPORT EDGAR
  6. Oct 6, 2023425 AMENDMENT NO. 1 TO FORM 8-K EDGAR
  7. Oct 6, 20238-K/A AMENDMENT NO. 1 TO FORM 8-K EDGAR
  8. Oct 4, 2023425 CURRENT REPORT EDGAR
  9. Oct 4, 20238-K CURRENT REPORT EDGAR
  10. Sep 14, 2023SEC STAFF LETTER EDGAR
  11. Sep 12, 2023EFFECT EDGAR
  12. Sep 12, 2023424B3 PROSPECTUS EDGAR
  13. Sep 12, 2023CORRESP EDGAR
  14. Sep 12, 2023S-4/A REGISTRATION STATEMENT EDGAR
  15. Aug 30, 2023S-4/A REGISTRATION STATEMENT EDGAR
  16. Aug 29, 2023CORRESP EDGAR
  17. Aug 28, 2023UPLOAD EDGAR
  18. Aug 25, 2023SEC STAFF LETTER EDGAR
  19. Aug 14, 202310-Q QUARTERLY REPORT EDGAR
  20. Aug 14, 20238-K CURRENT REPORT EDGAR

The 73 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 6 such filings since October 2021:

  1. Feb 8, 2023SC 13G/A
  2. Feb 8, 2023SC 13G/A
  3. Feb 14, 2022SC 13G/A
  4. Feb 1, 2022SC 13G/A
  5. Feb 1, 2022SC 13G/A
  6. Nov 8, 2021SC 13G

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32